Panaccione, R., Louis, E., Colombel, J., D'Haens, G., Peyrin-Biroulet, L., Dubinsky, M., . . . Ferrante, M. (2025). Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: Post hoc analysis of the INSPIRE and COMMAND phase 3 studies. Journal of Crohn's and Colitis, 19 (1) (2025-01-11. https://doi.org/10.1093/ecco-jcc/jjaf005
Παραπομπή σε μορφή Chicago (17η εκδ.)Panaccione, Remo, et al. "Risankizumab Efficacy and Safety Based on Prior Inadequate Response or Intolerance to Advanced Therapy: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies." Journal of Crohn's and Colitis, 19 (1) (2025-01-11 2025. https://doi.org/10.1093/ecco-jcc/jjaf005.
Παραπομπή σε μορφή MLA (9th εκδ.)Panaccione, Remo, et al. "Risankizumab Efficacy and Safety Based on Prior Inadequate Response or Intolerance to Advanced Therapy: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies." Journal of Crohn's and Colitis, 19 (1) (2025-01-11, 2025, https://doi.org/10.1093/ecco-jcc/jjaf005.